GlobeNewswire Inc.··Zealand PharmaZealand Pharma's Petrelintide Shows Promise in Obesity Drug Race
Zealand Pharma reports positive Phase 2 data for petrelintide, achieving 10.7% weight loss versus 1.7% placebo with favorable safety profile.
RHHBYZLDPYobesityweight management